Press Release | September 5, 2023
Star Therapeutics raises $90 million financing to accelerate its pipeline of novel antibody therapies and growth of its portfolio companies
Read More
News | August 25, 2023
Investing long-term in the cell & gene therapies of the future (Podcast with Geeta Vemuri and David McCall)
Read More
Press Release | August 23, 2023
Pyxis Oncology Successfully Completes Acquisition of Apexigen
Read More
News | August 17, 2023
Patent Awarded for Primary Template-Directed Amplification, Further Strengthening BioSkryb Genomics’ Core Technologies
Read More
